All about Eve.

Each year, around one million women are diagnosed with gynaecological cancer worldwide.

That’s one million reasons to have a charity like The Eve Appeal, which funds pioneering research into gynaecological cancers.

In the UK, ovarian cancer is the most common and fatal gynaecological cancer - which is why it is our most urgent focus.

When it is detected at its most advanced stage, over 85% of women suffering with ovarian cancer will die from the disease, but when it is detected in the early stages, 95% of women will survive.

So clearly there is work to be done.

The Eve Appeal is supporting a 10 year programme that is dedicated to funding research into the early detection, prevention and treatment of ovarian cancer.

The research team forms the Gynaecological Cancer Research Unit at University College London. It comprises an internationally recognised team led by Professor Ian Jacobs, one of the world’s foremost gynaecological oncologists.

Gynaecological cancers affect a woman’s reproductive system, including the ovaries, cervix, and womb. Despite progress in our understanding of how ovarian cancer develops, the overall prognosis for a woman diagnosed with the disease has changed very little over the last 30 years - and shows the least improvement compared to other cancers.

For some gynaecological cancers, there has been progress in screening and advances in treatment of the disease over the last few decades. For others, the story is one of limited success.

The Unit aims to develop techniques capable of reducing the number of women dying from ovarian cancer by 50% over the next 10 years.

And The Eve Appeal aims to raise funds for the research to continue.

It’s a major undertaking. But the real challenge is to save the lives of women who develop gynaecological cancer.